# Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke

> **NCT00227994** · PHASE4 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 40 (actual)

## Conditions studied

- Cerebrovascular Accident

## Interventions

- **DRUG:** Galantamine
- **DRUG:** Donepezil

## Key facts

- **NCT ID:** NCT00227994
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2005-01
- **Final completion:** 2005-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00227994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00227994, "Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00227994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*